AF_0189 is produced via heterologous expression systems, with two primary approaches documented:
| Method | Details |
|---|---|
| E. coli Expression | Full-length protein with His-tag, purified via nickel affinity chromatography |
| Baculovirus System | Partial-length protein, purified under non-denaturing conditions |
Host Compatibility: E. coli is preferred for high-yield production, while baculovirus systems may preserve post-translational modifications .
Stability: Repeated freeze-thaw cycles are discouraged; storage at -20°C/-80°C is recommended .
Despite its uncharacterized status, AF_0189 is part of the A. fulgidus genome, which encodes metabolic pathways (e.g., sulfate reduction, TCA cycle) and DNA replication machinery . While no direct functional data exists for AF_0189, its genomic context suggests potential roles in:
Protein-Protein Interactions: Hypothetical involvement in complexes analogous to A. fulgidus RFC (clamp loader) or PCNA (sliding clamp) systems .
Thermotolerance: Structural adaptations to hyperthermophilic environments, as seen in other A. fulgidus proteins .
No experimental evidence links AF_0189 to specific biochemical pathways .
Limited interaction data; potential partners remain unverified .
AF_0189 serves as a tool for studying archaeal protein biology:
Differences between E. coli- and baculovirus-derived AF_0189 highlight production trade-offs:
KEGG: afu:AF_0189
STRING: 224325.AF0189
AF_0189 is an uncharacterized protein from the hyperthermophilic archaeon Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 / JCM 9628 / NBRC 100126). This protein is of particular research interest because it comes from an extremophile organism that thrives in high-temperature environments. As an uncharacterized protein with UniProt accession number O30049, AF_0189 presents opportunities for novel functional discoveries in extremophile biology. The protein consists of 96 amino acids with the sequence: MPTHQCHIIRAVPVVRYVVALLHWLLWRVVVIIAISVPVFHHPFRNLRPCHFRPSWVCNRILRTSSFPMVLPSQHRALPSHQHQHYANLLPIHFTS .
For optimal preservation of protein structure and activity, store AF_0189 recombinant protein at -20°C for regular use or -80°C for extended storage. The protein is typically provided in a Tris-based buffer with 50% glycerol to maintain stability. Avoid repeated freeze-thaw cycles, as these can degrade protein structure and function. For active research, working aliquots can be maintained at 4°C for up to one week . When designing experiments, incorporate proper controls to account for potential activity changes due to storage conditions.
When designing experiments for uncharacterized proteins like AF_0189, follow a systematic approach:
Begin with a specific research question about the protein's function, structure, or interactions
Define your variables clearly: independent variables (experimental conditions you'll manipulate) and dependent variables (measurements you'll take)
Develop a testable hypothesis based on bioinformatic predictions or homology with known proteins
Design treatments to manipulate your independent variables (temperature, pH, substrates, etc.)
Plan appropriate measurement methods for your dependent variables (activity assays, binding studies, etc.)
Before conducting wet-lab experiments with AF_0189, researchers should implement a comprehensive bioinformatic analysis pipeline:
| Analysis Type | Purpose | Recommended Tools |
|---|---|---|
| Sequence homology | Identify potential functional domains and evolutionary relationships | BLAST, HMMER, CLUSTAL |
| Secondary structure prediction | Predict protein folding patterns | PSIPRED, JPred |
| Transmembrane domain analysis | Determine if AF_0189 is membrane-associated | TMHMM, Phobius |
| 3D structure prediction | Generate structural models for function hypothesis | AlphaFold2, RoseTTAFold |
| Protein-protein interaction prediction | Identify potential binding partners | STRING, PSICQUIC |
This systematic approach provides a foundation for hypothesis generation and experimental design. The hydrophobic character suggested by the amino acid sequence (containing multiple leucine, valine, and isoleucine residues) may indicate membrane association or involvement in protein-protein interactions, which should guide initial experimental approaches .
For optimal expression and purification of recombinant AF_0189, consider the following methodological approach:
Expression system selection: Since AF_0189 originates from a hyperthermophilic archaeon, consider using a thermophilic expression system or E. coli strains optimized for thermostable proteins
Vector design: Include appropriate affinity tags that won't interfere with the protein's native structure; consider thermal stability of the tags
Expression conditions: Test various induction temperatures (25-37°C) and IPTG concentrations to optimize soluble protein yield
Purification strategy:
Initial capture: Affinity chromatography based on vector-designed tags
Intermediate purification: Ion exchange chromatography
Polishing: Size exclusion chromatography
Quality control checks:
SDS-PAGE for purity assessment
Western blot for identity confirmation
Mass spectrometry for precise molecular weight determination
When reporting purification results, present both tabular yield data and representative gel images to demonstrate purity across purification steps. Tagging strategies should be carefully considered, as the tag type will be determined during the production process to optimize protein stability and function .
To determine the cellular localization of AF_0189, implement a multi-method experimental design:
Computational prediction:
Analyze sequence for signal peptides, transmembrane domains, and localization signals
Use tools like PSORT, SignalP, and TMHMM as preliminary guidance
Fluorescence microscopy approaches:
Generate GFP-tagged AF_0189 constructs for expression in archaeal model systems
Use confocal microscopy to visualize cellular distribution
Co-localize with known compartment markers
Subcellular fractionation:
Develop fractionation protocols optimized for archaeal cells
Analyze each fraction using Western blotting with anti-AF_0189 antibodies
Compare distribution patterns with known compartment markers
Immunogold electron microscopy:
Use specific antibodies against AF_0189 with gold-conjugated secondary antibodies
Visualize precise localization at ultrastructural level
Design your experimental controls carefully to account for potential artifacts from protein tags or overexpression. When reporting results, present both visual data (microscopy images) and quantitative analysis of protein distribution across cellular compartments .
To systematically investigate AF_0189's potential binding partners and interactions, implement a multi-layered experimental strategy:
In silico prediction:
Use structure-based docking to predict interaction partners
Analyze protein surface for potential interaction domains
Affinity purification coupled with mass spectrometry (AP-MS):
Express tagged AF_0189 in native or model organisms
Purify AF_0189 along with bound partners
Identify partners through mass spectrometry
Validate interactions with reciprocal pull-downs
Yeast two-hybrid screening:
Use AF_0189 as bait against archaeal genomic libraries
Confirm positive interactions with secondary screens
Surface plasmon resonance (SPR) or bio-layer interferometry (BLI):
Quantify binding kinetics of predicted interactions
Determine association/dissociation constants
Proximity labeling approaches:
Use BioID or APEX2 fusions to identify proximal proteins in cellular context
When analyzing interaction data, create network visualization maps to identify functional clusters and apply appropriate statistical tests to distinguish significant interactions from background. The full-length protein structure should be considered when designing constructs to preserve potential binding domains .
When designing experiments to investigate how extreme conditions affect AF_0189, implement a structured approach that reflects the hyperthermophilic origin of Archaeoglobus fulgidus:
Temperature stability studies:
Measure protein stability across 20-100°C range using differential scanning calorimetry
Assess activity retention after heat exposure
Compare stability with and without stabilizing agents
pH tolerance analysis:
Test structural stability and activity across pH 2-10
Use circular dichroism to monitor secondary structure changes
Implement activity assays at various pH values
Salt concentration effects:
Examine protein behavior in salt concentrations from 0-2M
Measure changes in solubility, oligomerization state, and activity
Use light scattering to assess aggregation tendencies
Pressure effects:
If available, use specialized equipment to test function under high pressure
Compare with other proteins from deep-sea organisms
Combined stress factors:
Design factorial experiments examining interactions between temperature, pH, and salt
Use response surface methodology to identify optimal and limiting conditions
Present results using heat maps or contour plots showing activity/stability across condition combinations. Include appropriate statistical analyses of variance (ANOVA) to determine significant factors affecting protein behavior. Such experiments provide valuable insights not only into AF_0189 specifically but may also reveal general principles of protein adaptation to extreme environments .
When analyzing experimental data from AF_0189 functional studies, implement rigorous statistical approaches tailored to biochemical research:
Data preparation and screening:
Check for normality using Shapiro-Wilk or Kolmogorov-Smirnov tests
Identify and address outliers using standardized residuals
Transform data if necessary to meet parametric test assumptions
Appropriate statistical tests selection:
For comparing two conditions: t-test (parametric) or Mann-Whitney U (non-parametric)
For multiple conditions: ANOVA with appropriate post-hoc tests (Tukey's HSD or Bonferroni correction)
For relationship analysis: correlation and regression models
Advanced multivariate analysis:
Principal component analysis (PCA) for data dimensionality reduction
Cluster analysis to identify patterns in response profiles
MANOVA for experiments with multiple dependent variables
Effect size calculation:
Report Cohen's d or similar metrics alongside p-values
Calculate confidence intervals to indicate precision of estimates
Power analysis:
Determine appropriate sample sizes for experimental design
Report achieved power for non-significant results
Statistical software packages like jamovi or SPSS can facilitate these analyses. When reporting results, include both descriptive statistics (mean, standard deviation) and inferential statistics (test statistic, degrees of freedom, p-value, effect size). This comprehensive approach ensures reliable interpretation of AF_0189 functional data .
When presenting complex experimental data from AF_0189 research, follow these structured guidelines:
Organize data from general to specific:
Begin with an overview of experimental parameters and conditions
Present baseline characteristics before specific findings
Ensure data directly addresses the research questions
Choose appropriate presentation formats:
Text: Use for interpretations and highlighting key findings
Tables: Present precise numerical values and statistical comparisons
Figures: Illustrate trends, relationships, and structural data
Design effective figures:
Use consistent formatting and clear labeling
Choose appropriate visualization types (bar charts for comparisons, line graphs for trends, heat maps for multi-parameter data)
Include error bars and statistical significance indicators
Create informative tables:
Use clear, concise titles that summarize content
Organize similar data in columns for easier comparison
Include footnotes for methodological details rather than cluttering the main table
Follow scientific writing best practices:
Write in past tense when describing results
Present data with their interpretation, not just raw values
Avoid redundancy between text, tables, and figures
When reporting AF_0189 experimental results, ensure all figures and tables are self-explanatory with appropriate titles, labels, and legends. Use consistent units throughout, and provide details on statistical tests applied. This approach ensures clarity and enables readers to fully understand the significance of your findings .
When faced with contradictory results in AF_0189 research, implement this systematic approach for analysis and presentation:
Verification steps:
Repeat experiments with identical conditions to confirm reproducibility
Review all experimental protocols for potential methodological differences
Check reagent quality, including protein batch variation
Exploration of contradictions:
Design controlled experiments specifically targeting the contradictory variables
Systematically modify one parameter at a time to identify critical factors
Consider environmental variables (temperature, pH, buffer composition)
Statistical analysis of contradictions:
Apply meta-analysis techniques when comparing across studies
Use Bayesian approaches to incorporate prior knowledge
Calculate confidence intervals to assess overlap between contradictory results
Presentation framework:
Present contradictory data side by side in tables or figures for direct comparison
Use clear visual distinctions between different experimental conditions
Include a comprehensive methods section detailing all relevant variables
Interpretation guidelines:
Consider multiple working hypotheses that could explain contradictions
Discuss implications of each potential explanation
Propose specific experiments to resolve contradictions
When reporting contradictory results, maintain objectivity and avoid dismissing unexpected findings. Present a balanced view of all data and acknowledge limitations. This approach not only demonstrates scientific integrity but may lead to novel insights about AF_0189's behavior under varying conditions .
When studying proteins from extremophile organisms like Archaeoglobus fulgidus, researchers should address several key ethical considerations:
Biodiversity and conservation:
Ensure sampling methods from extreme environments are sustainable
Obtain appropriate permits for collection from protected habitats
Consider impact on microbial ecosystem balance
Responsible resource sharing:
Deposit sequence data in public databases with complete metadata
Share recombinant constructs with the scientific community
Provide detailed methodologies to enable reproducibility
Intellectual property and indigenous knowledge:
Acknowledge indigenous knowledge about extremophile habitats
Develop fair benefit-sharing agreements when applicable
Navigate patenting issues with transparency
Laboratory safety considerations:
Implement appropriate biosafety measures, even for non-pathogenic organisms
Assess environmental risks of genetically modified extremophile proteins
Establish protocols for safe disposal of experimental materials
Research integrity:
Maintain detailed records of all experimental procedures
Report all results, not just those supporting hypotheses
Acknowledge limitations of experimental approaches
When planning research involving AF_0189 or other extremophile proteins, incorporate these ethical considerations into your experimental design from the earliest stages. This ensures not only regulatory compliance but also promotes sustainable and equitable scientific advancement in this specialized field .
Developing reliable controls for experiments with uncharacterized proteins like AF_0189 requires a systematic approach:
Negative controls:
Buffer-only conditions matching the protein storage medium
Heat-denatured protein samples to control for non-specific effects
Unrelated proteins of similar size/structure to detect non-specific interactions
Positive controls:
Well-characterized proteins from the same organism or family
Synthetic peptides corresponding to predicted active domains
Known activities expected based on bioinformatic predictions
Internal controls:
Multiple protein concentrations to establish dose-dependency
Time-course measurements to confirm kinetic expectations
Replicates across different protein preparations
Methodological controls:
Site-directed mutants targeting predicted functional residues
Tagged vs. untagged protein comparisons to assess tag interference
Alternative methods measuring the same parameter
Experimental design considerations:
Randomization of sample processing order
Blinding of sample identity during analysis when possible
Inclusion of internal standards for quantitative measurements
To develop effective antibodies against AF_0189 for research applications, implement this comprehensive strategy:
Epitope selection:
Analyze protein sequence for antigenic regions using prediction algorithms
Consider accessibility based on predicted structural models
Select multiple epitopes from different regions to increase success probability
Antibody production strategies:
Polyclonal antibodies: Immunize rabbits or other suitable animals with purified recombinant AF_0189
Monoclonal antibodies: Implement hybridoma technology using immunized mice
Recombinant antibodies: Generate phage display libraries and screen against AF_0189
Validation protocols:
Western blotting against purified protein and cellular extracts
Immunoprecipitation efficiency testing
Immunofluorescence specificity confirmation
Cross-reactivity assessment against related proteins
Optimization guidelines:
Test different blocking agents to minimize background
Determine optimal antibody concentrations through titration
Evaluate various fixation methods for immunocytochemistry
Quality control measures:
Implement lot-to-lot consistency testing
Assess stability under various storage conditions
Document specificity with knockout/knockdown controls when possible
When reporting antibody development, include detailed methods covering immunization protocols, screening procedures, and validation results. Present data showing antibody specificity and sensitivity, including appropriate positive and negative controls. This systematic approach ensures the generation of reliable research tools for studying the uncharacterized AF_0189 protein .
For predicting the structure and function of an uncharacterized protein like AF_0189, implement these computational modeling approaches:
Sequence-based analysis:
Profile-based methods (PSI-BLAST, HHpred) to detect remote homologs
Conservation analysis to identify functionally important residues
Disorder prediction to identify flexible regions
Ab initio structure prediction:
AlphaFold2 or RoseTTAFold for highly accurate structure prediction
Model quality assessment using metrics like pLDDT scores
Ensemble modeling to capture conformational diversity
Structure-based function prediction:
3D template matching against function-annotated structure databases
Active site prediction using CASTp, POCASA, or similar tools
Electrostatic surface analysis for interaction potential
Molecular dynamics simulations:
Stability assessment under different temperature conditions
Conformational sampling to identify potential functional states
Solvent accessibility analysis
Integrated approaches:
Combined sequence-structure-function workflow
Consensus predictions from multiple methods
Experimental validation of key predictions
When implementing these approaches, consider that AF_0189 comes from a hyperthermophilic organism, which may require specialized force fields or parameters for accurate modeling. Present computational results with appropriate validation metrics and highlight the confidence level of various predictions. Use visualization techniques that clearly communicate structural features and potential functional sites. This comprehensive computational analysis provides a foundation for subsequent experimental characterization of this uncharacterized protein .